These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 21808751)

  • 1. Effects of orally disintegrating vs regular olanzapine tablets on body weight, eating behavior, glycemic and lipid indices, and gastrointestinal hormones: a randomized, open comparison in outpatients with bipolar depression.
    Bobo WV; Epstein RA; Shelton RC
    Ann Clin Psychiatry; 2011 Aug; 23(3):193-201. PubMed ID: 21808751
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Orally disintegrating olanzapine induces less weight gain in adolescents than standard oral tablets.
    Crocq MA; Guillon MS; Bailey PE; Provost D
    Eur Psychiatry; 2007 Oct; 22(7):453-4. PubMed ID: 17761403
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A randomized controlled trial of the effect of sublingual orally disintegrating olanzapine versus oral olanzapine on body mass index: the PLATYPUS Study.
    Karagianis J; Grossman L; Landry J; Reed VA; de Haan L; Maguire GA; Hoffmann VP; Milev R
    Schizophr Res; 2009 Aug; 113(1):41-8. PubMed ID: 19535229
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term weight loss observed with olanzapine orally disintegrating tablets in overweight patients with chronic schizophrenia. A 1 year open-label, prospective trial.
    Chawla B; Luxton-Andrew H
    Hum Psychopharmacol; 2008 Apr; 23(3):211-6. PubMed ID: 18219624
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cost-effectiveness of several atypical antipsychotics in orally disintegrating tablets compared with standard oral tablets in the treatment of schizophrenia in the United States.
    Ascher-Svanum H; Furiak NM; Lawson AH; Klein TM; Smolen LJ; Conley RR; Culler SD
    J Med Econ; 2012; 15(3):531-47. PubMed ID: 22304338
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An exploratory analysis of factors associated with weight change in a 16-week trial of oral vs. orally disintegrating olanzapine: the PLATYPUS study.
    Karagianis J; Landry J; Hoffmann VP; Grossman L; De Haan L; Maguire G; Milev R; Holt S
    Int J Clin Pract; 2010 Oct; 64(11):1520-1529. PubMed ID: 20846199
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Weight loss during therapy with olanzapine orally disintegrating tablets: two case reports.
    Kozumplik O; Uzun S; Jakovljević M
    Psychiatr Danub; 2009 Mar; 21(1):72-4. PubMed ID: 19270625
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Orally disintegrating and oral standard olanzapine tablets similarly elevate the homeostasis model assessment of insulin resistance index and plasma triglyceride levels in 12 healthy men: a randomized crossover study.
    Vidarsdottir S; Vlug P; Roelfsema F; Frölich M; Pijl H
    J Clin Psychiatry; 2010 Sep; 71(9):1205-11. PubMed ID: 20441717
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Olanzapine shifts the temporal relationship between the daily acrophase of serum prolactin and cortisol concentrations rhythm in healthy men.
    Vidarsdottir S; Roelfsema F; Frolich M; Pijl H
    Psychoneuroendocrinology; 2009 Jun; 34(5):705-12. PubMed ID: 19131173
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lower weight gain with the orally disintegrating olanzapine than with standard tablets in first-episode never treated psychotic patients.
    Arranz B; San L; Dueñas RM; Centeno M; Ramirez N; Salavert J; Del Moral E
    Hum Psychopharmacol; 2007 Jan; 22(1):11-5. PubMed ID: 17191265
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of olanzapine orally disintegrating tablet versus oral standard tablet on body weight in patients with schizophrenia: a randomized open-label trial.
    Kusumi I; Honda M; Uemura K; Sugawara Y; Kohsaka M; Tochigi A; Koyama T
    Prog Neuropsychopharmacol Biol Psychiatry; 2012 Mar; 36(2):313-7. PubMed ID: 22119746
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cost-effectiveness of aripiprazole orally disintegrating tablets in the treatment of schizophrenia in China.
    Lin Z; Xuan J
    Expert Rev Pharmacoecon Outcomes Res; 2020 Oct; 20(5):549-557. PubMed ID: 32757968
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effectiveness and medication acceptance of olanzapine disintegrating tablets compared to standard olanzapine tablets in acutely treated psychiatric patients.
    Czekalla J; Wagner T; Schacht A; Kluge M; Kinon B
    Patient Prefer Adherence; 2007 Dec; 1():19-27. PubMed ID: 19956444
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Patients' preference for olanzapine orodispersible tablet compared with conventional oral tablet in a multinational, randomized, crossover study.
    Bitter I; Treuer T; Dilbaz N; Oyffe I; Ciorabai EM; Gonzalez SL; Ruschel S; Salburg J; Dyachkova Y
    World J Biol Psychiatry; 2010 Oct; 11(7):894-903. PubMed ID: 20653494
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Pharmaceutical formulations and adherence to pharmacological treatment in psychiatry: the example of oral disintegrating tablet of olanzapine].
    Cecchi C; Canonico PL
    Riv Psichiatr; 2012; 47(1):30-9. PubMed ID: 22358215
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Short-term treatment with olanzapine does not modulate gut hormone secretion: olanzapine disintegrating versus standard tablets.
    Vidarsdottir S; Roelfsema F; Streefland T; Holst JJ; Rehfeld JF; Pijl H
    Eur J Endocrinol; 2010 Jan; 162(1):75-83. PubMed ID: 19779025
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetics of olanzapine after single-dose oral administration of standard tablet versus normal and sublingual administration of an orally disintegrating tablet in normal volunteers.
    Markowitz JS; DeVane CL; Malcolm RJ; Gefroh HA; Wang JS; Zhu HJ; Donovan JL
    J Clin Pharmacol; 2006 Feb; 46(2):164-71. PubMed ID: 16432268
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effectiveness of two formulations of oral olanzapine in patients with schizophrenia or bipolar disorder in a natural setting: results from a 1-year European observational study.
    Kraemer S; Chartier F; Augendre-Ferrante B; Psarra V; D'yachkova Y; Beselin A; Rouillon F
    Hum Psychopharmacol; 2012 May; 27(3):284-94. PubMed ID: 22473831
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Olanzapine orally disintegrating tablet: a review of efficacy and compliance.
    San L; Casillas M; Ciudad A; Gilaberte I
    CNS Neurosci Ther; 2008; 14(3):203-14. PubMed ID: 18801113
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Orally disintegrating olanzapine for the treatment of a manic patient with esophageal stricture plus chronic pharyngitis.
    Shen YC; Lee MY; Lin CC; Chen CH
    Prog Neuropsychopharmacol Biol Psychiatry; 2007 Mar; 31(2):541-2. PubMed ID: 17029723
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.